View Press Releases
-
WCG Leads the Way and Sets a New Standard - Announcing the Formation of WCG IRB and the Launch of New WCG IRB Connexus™
PRINCETON, NJ - Oct 12, 2020 - WCG announced today the unification of its five industry-leading IRBs – Western IRB (WIRB), Copernicus Group IRB (CGIRB), Midlands IRB (MLIRB), New England IRB (NEIRB), and Aspire IRB – into the single WCG IRB brand
Oct 12, 2020
-
Mogrify introduces EpiMOGRIFY platform to systematically identify epigenetic switches driving cell identity and cell maintenance
CAMBRIDGE, UNITED KINGDOM - Dec 10, 2020 - Cambridge, UK, 9th October 2020: Mogrify Limited (Mogrify®), a UK company aiming to transform the development of ex vivo cell therapies and pioneer the field of in vivo reprogramming therapies, today announced the introduction of EpiMOGRIFY
Oct 12, 2020
-
Study Shows Proof of Concept of BioIVT HEPATOPAC Cultures with Targeted Assay to Evaluate Bioactivation Potential and Drug-induced Liver Injury (DILI) Risk
WESTBURY, NY - Oct 12, 2020 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced the publication of research describing the use of HEPATOPAC® cultures with a targeted in vitro assay to identify small molecule drugs with high potential for drug-induced liver injury (DILI)
Oct 12, 2020
-
Alfa Chemistry Materials Offers Wide Options of Resins for Decoration or Manufacture of Plastics
NY, NY - Oct 10, 2020 - On October 8, 2020, Alfa Chemistry Materials announces to provide wide options of resins for customers worldwide, which have broad applications in decoration, manufacture of plastics as well as other fields
Oct 9, 2020
-
Abzena invests $60m into cGMP manufacturing capacity
SAN DIEGO, CA, UNITED KINGDOM - Oct 8, 2020 - Leading contract provider of integrated discovery, development and manufacturing services for biologics and bioconjugates, Abzena, has invested $60m into a new facility for late phase and commercial cGMP manufacturing
Oct 8, 2020
-
Solentim to supply cell line development solutions for Samsung Biologics’ new R&D center in San Francisco
BOURNEMOUTH, UNITED KINGDOM - Oct 7, 2020 - Solentim is pleased to announce the adoption of its VIPS single cell seeding platform and Cell Metric® CLD into Samsung Biologics new research and development facility in San Francisco, CA
Oct 7, 2020
-
Sandia helps safeguard biological data threatened during COVID-19 pandemic
CAMBRIDGE, UNITED KINGDOM - Oct 6, 2020 - A partnership between Sandia National Laboratories and the Boston firm BioBright LLC to improve the security of synthetic biology equipment has become more relevant after the United States and others issued warnings that hackers were using the COVID-19 pandemic to increase their activities
Oct 6, 2020
-
NVIDIA and PetaGene Combine Genomic Technologies to Address Critical Analysis Bottlenecks
CAMBRIDGE, UK - Oct 6, 2020 - PetaGene and NVIDIA announce seamless integration of PetaGene's PetaSuite tools as a standard part of NVIDIA Clara Parabricks Pipelinesx
Oct 6, 2020
-
TrialScope Adds Eisai to Its Community of Study Sponsors
JERSEY CITY, NJ, US - Oct 6, 2020 - TrialScope, the global leader in clinical trial disclosure and transparency management technology, has added a new study sponsor to its growing customer roster
Oct 6, 2020
-
InSysBio to release the new version of DBSolve Optimum
MOSCOW, RUSSIA - Oct 6, 2020 - InSysBio, one of the worlds pioneers of Quantitative Systems Pharmacology (QSP) modeling, releases the new version of mathematical simulation workbench DBSolveOptimum 2020
Oct 6, 2020
-
Sterling Pharma Solutions launches £11 million Material Science Centre
- Sep 27, 2020 - Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has officially opened its new multi-million-pound Material Science Centre (MSC), after announcing the investment last year
Oct 6, 2020
-
Abzena appoints Giovanni Escobar as SVP and Site Head of Bristol, Pennsylvania Operations
CAMBRIDGE, UNITED KINGDOM - Oct 5, 2020 - Abzena, a leading Partner Research Organization (PRO) for biopharmaceutical outsourced solutions from concept to clinic and into GMP manufacturing has announced the appointment of Giovanni Escobar as Senior Vice President (SVP) and Site Head of its Bristol Operations
Oct 5, 2020
-
VERICHEM LABORATORIES OFFERS LIQUID STABLE, READY-TO-USE, MULTI-ANALYTE ELECTROLYTE STANDARD KIT
PROVIDENCE, RI, UNITED STATES - Oct 5, 2020 - VERICHEM LABORATORIES is pleased to announce the availability of a ready-to-use, liquid stable Electrolyte Standard Kit
Oct 5, 2020
-
Panthera Biopartners concludes Series A financing with Gresham House Ventures as major investor
PRESTON, UNITED KINGDOM - Oct 2, 2020 - Panthera Biopartners (Panthera) has completed a Series A funding round with Gresham House Ventures as a major investor
Oct 2, 2020
-
A vulnerability in IBM Maximo asset management system, discovered by Positive Technologies, was fixed
FRAMINGHAM, MA, UNITED STATES - Oct 1, 2020 - Framingham, MA (October 1, 2020) -- A vulnerability in IBM Maximo Asset Management software was discovered by Positive Technologies experts Andrey Medov and Arseny Sharoglazov
Oct 1, 2020
-
OSF HealthCare Implements New Digital Solutions to Help Consumers Find the Right Care Online
BOSTON, MA, UNITED STATES - Oct 1, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, today announced that OSF HealthCare, a not-for-profit Catholic health system based in Illinois, is now connecting consumers with care through Kyruus ProviderMatch® for Consumers
Oct 1, 2020
-
AARDEX Group partners with BIOCORP to extend digital solutions for precision medication adherence
ISSOIRE, FRANCE - Oct 1, 2020 - Belgium-based AARDEX Group, the world leader in medication adherence solutions, today announced a strategic partnership with BIOCORP, a French company specialized in the design, development and manufacture of innovative medical devices
Oct 1, 2020
-
Sterling Pharma Solutions acquires API facility in the US
GERMANTOWN, WI, US - Sep 30, 2020 - Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has announced its acquisition of Alcamis Germantown, Wisconsin facility in the US
Sep 30, 2020
-
Synthetic Biology start up NanoSyrinx secures capital to develop its fully customisable platform for intra-cellular engineering
COVENTRY, UNITED KINGDOM - Sep 30, 2020 - NanoSyrinx, an emerging biotechnology company developing new therapeutic modalities for Cell & Gene editing, announced the closing of a Pre-Seed financing led by M Ventures (Amsterdam, The Netherlands), the corporate venture capital arm of Merck
Sep 30, 2020
-
Standigm and SK holdings C&C Release an AI-Based Target Identification Platform, iCLUE&ASK™, to Accelerate Drug Discovery Process
SEOUL, SOUTH KOREA - Sep 29, 2020 - Standigm Inc. (Standigm), an artificial intelligence (AI)-based drug discovery company, and SK holdings C&C, Co
Sep 29, 2020